Iloprost has potent anti‐inflammatory properties on human monocyte‐derived dendritic cells

Abstract

In summary, our results provide evidence that iloprost profoundly affects the function of human myeloid DCs. Therefore, iloprost might also be a new therapeutical option for the treatment of asthma in humans.